Efficient in vivo base editing via single adenoassociated viruses with size-optimized genomes encoding compact adenine base editors (Jul, 10.1038/s41551-022-00911-4, 2022)

被引:13
作者
Davis, Jessie R.
Wang, Xiao
Witte, Isaac P.
Huang, Tony P.
Levy, Jonathan M.
Raguram, Aditya
Banskota, Samagya
Seidah, Nabil G.
Musunuru, Kiran
Liu, David R.
机构
[1] Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA
[2] Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA
[3] Howard Hughes Medical Institute, Harvard University, Cambridge, MA
[4] Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
[5] Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
[6] Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
[7] Laboratory of Biochemical Neuroendocrinology, Montreal Clinical Research Institute (IRCM), University of Montreal, Montreal, QC
关键词
Number:; NGS; 148363; Acronym:; -; Sponsor:; 950–231335; NSF; Sponsor: National Science Foundation; R01EY009339; R01HL148769; R35GM118062; RM1HG009490; U01AI142756; UG3AI150551; NIH; Sponsor: National Institutes of Health; HHMI; Sponsor: Howard Hughes Medical Institute; R35HL145203; NHLBI; Sponsor: National Heart; Lung; and Blood Institute; BMGF; Sponsor: Bill and Melinda Gates Foundation;
D O I
10.1038/s41551-022-00934-x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The viral delivery of base editors has been complicated by their size and by the limited packaging capacity of adeno-associated viruses (AAVs). Typically, dual-AAV approaches based on trans-splicing inteins have been used. Here we show that, compared with dual-AAV systems, AAVs with size-optimized genomes incorporating compact adenine base editors (ABEs) enable efficient editing in mice at similar or lower doses. Single-AAV-encoded ABEs retro-orbitally injected in mice led to editing efficiencies in liver (66%), heart (33%) and muscle (22%) tissues that were up to 2.5-fold those of dual-AAV ABE8e, and to a 93% knockdown (on average) of human PCSK9 and of mouse Pcsk9 and Angptl3 in circulation, concomitant with substantial reductions of plasma cholesterol and triglycerides. Moreover, three size-minimized ABE8e variants, each compatible with single-AAV delivery, collectively offer compatibility with protospacer-adjacent motifs for editing approximately 82% of the adenines in the human genome. ABEs encoded within single AAVs will facilitate research and therapeutic applications of base editing by simplifying AAV production and characterization, and by reducing the dose required for the desired level of editing. © 2022, The Author(s).
引用
收藏
页码:1317 / 1317
页数:1
相关论文
共 1 条
[1]  
Davis JR, 2022, NAT BIOMED ENG, V6, P1272, DOI 10.1038/s41551-022-00911-4